Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301Antonius A. Miller, Mark J. Ratain, Kouros Owzar et al.|Journal of Clinical Oncology|2009Cited by 207